A System to Diagnose Brain Diseases

Company Information



Medical Facilities & Services


Berkeley, CA

BrainScanology is changing how MRIs are analyzed.

It’s developed a brain disease diagnostic system. This system analyzes MRI brain scans to track the risks of neurological disorders including Bipolar Disorder, Attention-Deficit/Hyperactivity Disorder (ADHD), dementia, and Alzheimer’s disease.

This company was founded by a computational biologist who invented a breakthrough method for analyzing colon cancer screenings. BrainScanology measures a brain’s area, volume, and shape, while the current system in use measures only a brain’s area and volume.

This company is targeting a market in need of help. Brain disease patients often face barriers such as receiving a proper diagnosis, an inability to diagnose diseases early, and no method for preventative tracking.

Health providers, meanwhile, must deal with a fragmented imaging and diagnostic pipeline, and significant wait times for results that delay life-saving treatment plans.

BrainScanology solves these problems. Its system results in diagnostic times that are 40x shorter. It also allows for early detection of disorders, and the ability to track a disease’s progression.

Notably, M&A activity in the medical imaging space has included a couple of blockbuster deals. GE recently acquired Amersham PLC, a medical imaging company, for $9.5 billion. And in 2019, Fujifilm acquired Hitachi’s medical imaging business for $1.5 billion.

Team Background

William Jagust - Advisor
Harini Kumar - Co-Founder
Dave Nguyen - Co-Founder & CEO
$73K (68%)
Current Valuation
$20 million Cap / 30% Discount
Min. Investment
Deal Type
Title III
(For all investors)
Offering Type
Learn more on WeFunder